MENU
IBO
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Impact BioMedical (IBO) Ownership - Who owns Impact BioMedical?
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases... Show more
Profile
Industry
N/A
Address
275 Wiregrass Parkway
Phone
+1 585 325-3610
Employees
N/A
Web
https://www.impactbiomedinc.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.18M
P/E Ratio
14.22
Total Cash
2.67M
Projected Growth
N/A
Total Debt
8.01M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.23
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IBO
Capitalization
18.2M
P/E Ratio
14.22
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
2.67M
Total Cash/Share
0.23
Total Debt
8.01M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
31.3M
P/B Ratio
0.53
Cash Flow
N/A
Earnings
0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
2.79
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
3.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
2.54
Shares Held By Institutions
250K
Shares Outstanding - Current
11.5M
Total Liabilities
12.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
8.966
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
275 Wiregrass Parkway
Phone
+1 585 325-3610
Employees
N/A
Web
https://www.impactbiomedinc.com